Nkarta Collaboration Achieves Cost-Effective Manufacturing in Tight Timelines
Nkarta is a clinical-stage cell therapy company focused on engineered natural killer, or NK, cells for the treatment of cancer.
Resources
Resources for the OmniaBio
DiscGenics Collaboration Successfully Develops Allogeneic Therapy to Enable Efficient Manufacturing
DiscGenics is a biopharmaceutical company that develops regenerative cell-based…
Collaborative Relationship Allows Avectas to Accelerate the Translation of SOLUPORE Into the Clinic
Avectas is an Ireland-based cell engineering technology company developing a unique intracellular delivery platform to enable ex vivo cell-based therapies.
The Cystic Fibrosis (CF) Canada Program in Individualized Therapy (CFIT)
Establishing a bank of 100 patient-derived iPSC lines and isogenic controls…
Process Development for Scaled-Up hESC/hiPSC Manufacturing
An optimized 14-day manufacturing workflow developed in < 12 months...
Manufacturing of Pluripotent Stem Cell-Derived Cardiomyocytes for Pre-Clinical Animal Studies
Translation of a cell therapy protocol from bench-scale to bioreactor…
Animal Component Free (ACF) Media Development for Cell Therapies
ACF media achieved comparable performance to serum containing…